Olivier Godement, Head of Product for OpenAI Platform, discusses OpenAI's enterprise deployment and collaboration with biotechnology company Amgen.
Prediction Not checkable as stated
Godement: Reinforcement fine-tuning will become the norm for pushing AI capability frontiers
“Pushing the frontier on, like, actual capabilities, my hunch is that RFT will pretty much become the norm. Like, you know, if you are actually pushing in your field, like, you know, intelligence, like, you know, to a pretty high point, like, at some point, lik…”
Prediction Not checkable as stated
Godement: Healthcare will benefit most from AI in next 1–2 years
“Frankly, I think healthcare is probably the industry that will benefit the most from AI in the next, like, year or two.”
Opinion
Godement: The November 2023 board crisis made OpenAI culturally stronger and more resilient
“I feel it made OpenEye stronger for real now, essentially, when I look after the fact. When I look at, you know, other, like, you know, news, like departures, or, you know, whatever, like, you know, bad news, essentially, I feel the company has built, like, yo…”
Opinion
Godement: The world suffers from a massive software shortage
“I buy completely the thesis that there is a massive software shortage. Like, in the world.”
Disclosure
Godement: OpenAI PMs stopped writing PRDs to vibe-code prototypes instead
“We started, like, essentially not doing, like, PRDs, like, product requirements documents. You know, classic PM thing. You write, like, five pages, like, my product does that, et cetera. And, you know, PMs have been basically VibeCoding prototypes.”
Assertion Supported
Godement: OpenAI models power live voice support features in T-Mobile app
“And so we've been working with T-Mobile pretty much for the past year at that point to basically automate like not only like text support but also voice support. And so today, like, you know, there are like features like in the T-Mobile app That if you call, a…”